Alizapride Side effects

sponsored
What is the dose of your medication?

Side effects of Alizapride in details

infoA side effect of any drug can be defined as the unwanted or undesired effect produced by the drug. The side effect can be major or in few medications minor that can be ignored. Side effects not only vary from drug to drug, but it also depends on the dose of the drug, the individual sensitivity of the person, brand or company which manufactures it. If side effects overweigh the actual effect of the medicine, it may be difficult to convince the patient to take the drug. Few patients get specific side effects to specific drugs; in that case, a doctor replaces the drug with another. If you feel any side effect and it troubles you, do not forget to share with your healthcare practitioner.
sponsored

Psychiatric disorders and central nervous system: Extrapyramidal symptoms, which can occur especially in children and young adults, even after a single dose of the medicine (acute and tardive dystonia, parkinsonian syndrome, akathisia).

Tardive dyskinesia in the case of prolonged treatment. Somnolencia, mareo, cefalea, insomnio. Drowsiness, dizziness, headache, insomnia.

Gastrointestinal disorders: Diarrhoea.

Endocrine disorders: amenorrhea, galactorrhea, gynecomastia, hyperprolactinemia. General disorders: allergic reactions, including anaphylaxis.

Alizapride contraindications

infoContraindication can be described as a special circumstance or a disease or a condition wherein you are not supposed to use the drug or undergo particular treatment as it can harm the patient; at times, it can be dangerous and life threatening as well. When a procedure should not be combined with other procedure or when a medicine cannot be taken with another medicine, it is called Relative contraindication. Contraindications should be taken seriously as they are based on the relative clinical experience of health care providers or from proven research findings.

Alizapride or hypersensitivity to any component of the formula.

Patients with a history of tardive dyskinesia with the use of neuroleptics.

Patients with known or suspected pheochromocytoma.

References

  1. European Chemicals Agency - ECHA. "Alizapride: The information provided here is aggregated from the "Notified classification and labelling" from ECHA's C&L Inventory. ". https://echa.europa.eu/information-o... (accessed September 17, 2018).
  2. KEGG. "Target-based classification of drugs". http://www.genome.jp/kegg-bin/get_ht... (accessed September 17, 2018).
  3. WHO ATC. "ATC Code: In the World Health Organization (WHO) Anatomical Therapeutic Chemical (ATC) classification system, the active substances are divided into different groups according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties.". https://www.whocc.no/atc_ddd_index/ (accessed September 17, 2018).

Reviews

The results of a survey conducted on ndrugs.com for Alizapride are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Alizapride. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.

User reports

Consumer reported side effects

No survey data has been collected yet


Consumer reviews


There are no reviews yet. Be the first to write one!


Your name: 
Email: 
Spam protection:  < Type 13 here

Information checked by Dr. Sachin Kumar, MD Pharmacology

| Privacy Policy
This site does not supply any medicines. It contains prices for information purposes only.
© 2003 - 2019 ndrugs.com All Rights Reserved